FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365442685> ?p ?o ?g. }

• W4365442685 endingPage "1193" @default.
• W4365442685 startingPage "1189" @default.
• W4365442685 abstract "Abstract DaxibotulinumtoxinA-lanm for injection (DAXI), a novel botulinum toxin type A formulation, contains a purified 150-kD core neurotoxin (daxibotulinumtoxinA) and proprietary stabilizing peptide (RTP004), and is approved for glabellar line treatment. As with any biologic product, DAXI may potentially be immunogenic and elicit unwanted antibody formation, possibly resulting in partial or complete treatment failure. The immunogenicity of DAXI was assessed in 2 double-blind, placebo-controlled, single-dose studies and an open-label safety study of up to 3 repeat treatments. Of the 2737 evaluable patients, none developed neutralizing antibodies to daxibotulinumtoxinA and 0.8% developed treatment-related nonneutralizing anti–daxibotulinumtoxinA-binding antibodies. Of evaluable patients exposed to RTP004 with either DAXI or placebo, 1.3% developed treatment-related anti–RTP004-binding antibodies, which were mostly transient. No patient developed binding antibodies to both daxibotulinumtoxinA and RTP004. All patients with treatment-related binding antibodies to daxibotulinumtoxinA or RTP004 achieved a clinical response (none or mild glabellar line severity) at Week 4 following each DAXI treatment cycle. The duration of clinical response was not different between treatment cycles when antibodies were detected vs when they were absent. Although the analysis population was small compared to the number of patients likely to receive repeated treatment in clinical practice, these results suggest that DAXI administration at the approved glabellar lines dose has low immunogenic potential and that nonneutralizing antibodies to daxibotulinumtoxinA or RTP004 occur infrequently and often transiently, and have no impact on clinical efficacy, safety, or duration of action. Real-world data encompassing larger numbers of patients is needed to substantiate these results. Level of Evidence: 3" @default.
• W4365442685 created "2023-04-15" @default.
• W4365442685 creator A5000424462 @default.
• W4365442685 creator A5002932244 @default.
• W4365442685 creator A5016278187 @default.
• W4365442685 creator A5021293751 @default.
• W4365442685 creator A5067344128 @default.
• W4365442685 creator A5080606523 @default.
• W4365442685 creator A5090826326 @default.
• W4365442685 date "2023-04-13" @default.
• W4365442685 modified "2023-09-26" @default.
• W4365442685 title "Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines" @default.
• W4365442685 cites W1972170005 @default.
• W4365442685 cites W2027142476 @default.
• W4365442685 cites W2034704564 @default.
• W4365442685 cites W2044815435 @default.
• W4365442685 cites W2055377082 @default.
• W4365442685 cites W2165068832 @default.
• W4365442685 cites W2598060151 @default.
• W4365442685 cites W2900976928 @default.
• W4365442685 cites W2905303601 @default.
• W4365442685 cites W2970627183 @default.
• W4365442685 cites W2979906288 @default.
• W4365442685 cites W2990095900 @default.
• W4365442685 cites W3048658573 @default.
• W4365442685 cites W3048761131 @default.
• W4365442685 cites W3128354425 @default.
• W4365442685 cites W3212182787 @default.
• W4365442685 cites W4315647508 @default.
• W4365442685 doi "https://doi.org/10.1093/asj/sjad101" @default.
• W4365442685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37051886" @default.
• W4365442685 hasPublicationYear "2023" @default.
• W4365442685 type Work @default.
• W4365442685 citedByCount "0" @default.
• W4365442685 crossrefType "journal-article" @default.
• W4365442685 hasAuthorship W4365442685A5000424462 @default.
• W4365442685 hasAuthorship W4365442685A5002932244 @default.
• W4365442685 hasAuthorship W4365442685A5016278187 @default.
• W4365442685 hasAuthorship W4365442685A5021293751 @default.
• W4365442685 hasAuthorship W4365442685A5067344128 @default.
• W4365442685 hasAuthorship W4365442685A5080606523 @default.
• W4365442685 hasAuthorship W4365442685A5090826326 @default.
• W4365442685 hasBestOaLocation W43654426851 @default.
• W4365442685 hasConcept C126322002 @default.
• W4365442685 hasConcept C142724271 @default.
• W4365442685 hasConcept C159654299 @default.
• W4365442685 hasConcept C203014093 @default.
• W4365442685 hasConcept C204787440 @default.
• W4365442685 hasConcept C27081682 @default.
• W4365442685 hasConcept C2780868878 @default.
• W4365442685 hasConcept C2908647359 @default.
• W4365442685 hasConcept C71924100 @default.
• W4365442685 hasConcept C90924648 @default.
• W4365442685 hasConcept C99454951 @default.
• W4365442685 hasConceptScore W4365442685C126322002 @default.
• W4365442685 hasConceptScore W4365442685C142724271 @default.
• W4365442685 hasConceptScore W4365442685C159654299 @default.
• W4365442685 hasConceptScore W4365442685C203014093 @default.
• W4365442685 hasConceptScore W4365442685C204787440 @default.
• W4365442685 hasConceptScore W4365442685C27081682 @default.
• W4365442685 hasConceptScore W4365442685C2780868878 @default.
• W4365442685 hasConceptScore W4365442685C2908647359 @default.
• W4365442685 hasConceptScore W4365442685C71924100 @default.
• W4365442685 hasConceptScore W4365442685C90924648 @default.
• W4365442685 hasConceptScore W4365442685C99454951 @default.
• W4365442685 hasFunder F4320315865 @default.
• W4365442685 hasIssue "10" @default.
• W4365442685 hasLocation W43654426851 @default.
• W4365442685 hasLocation W43654426852 @default.
• W4365442685 hasOpenAccess W4365442685 @default.
• W4365442685 hasPrimaryLocation W43654426851 @default.
• W4365442685 hasRelatedWork W1591820460 @default.
• W4365442685 hasRelatedWork W1934038313 @default.
• W4365442685 hasRelatedWork W2028450449 @default.
• W4365442685 hasRelatedWork W2029455707 @default.
• W4365442685 hasRelatedWork W2074827279 @default.
• W4365442685 hasRelatedWork W2085933985 @default.
• W4365442685 hasRelatedWork W2133907434 @default.
• W4365442685 hasRelatedWork W2377972480 @default.
• W4365442685 hasRelatedWork W2419379701 @default.
• W4365442685 hasRelatedWork W4233016836 @default.
• W4365442685 hasVolume "43" @default.
• W4365442685 isParatext "false" @default.
• W4365442685 isRetracted "false" @default.
• W4365442685 workType "article" @default.